Anti-tumor immunity is boosted by loss of TGFβ-driven tissue residency
Authors:
- 29 July 2025
- journal article
- editorial
- Published by Springer Nature in Nature Immunology
- Vol. 26 (8) , 1223-1224
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Lymph-node-derived stem-like but not tumor-tissue-resident CD8+ T cells fuel anticancer immunityNature Immunology, 2025
- CD8+ T cells in the cancer-immunity cycleImmunity, 2023
- Localization, tissue biology and T cell state — implications for cancer immunotherapyNature Reviews Immunology, 2023
- The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1/PD-L1 blockade in draining lymph nodesCell, 2022
- Discrete tissue microenvironments instruct diversity in resident memory T cell function and plasticityNature Immunology, 2021
- TCF1 in T cell immunity: a broadened frontierNature Reviews Immunology, 2021
- TGFβ biology in cancer progression and immunotherapyNature Reviews Clinical Oncology, 2020
- A guide to cancer immunotherapy: from T cell basic science to clinical practiceNature Reviews Immunology, 2020
- Defining ‘T cell exhaustion’Nature Reviews Immunology, 2019
- Defining CD8+ T cells that provide the proliferative burst after PD-1 therapyNature, 2016